1. Brown T, Koeller J, Beougher K, Golando J, Bonnem E, Von Hoff D: A phase I clinical trial of recombinant DNA gamma Interferon (GIFN). (Abstr) Proc Am Soc Clin Oncol 5: 225, 1986
2. Dianzani F, Salter L, Fleischman Jr WR, Zucca M: Immune interferon activates cells more slowly than does virus-induced interferon. Proc Soc Exp Biol Med 159: 94–97, 1978
3. Garnick MB, Reich SD, Maxwell B, Coval-Goldsmith S, Richie J, Rudnick SA: Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma. J Urol 139: 251–255, 1988
4. Muss HB: The role of biologic response modifiers in metastatic renal cell carcinoma. Semin Oncol 15: 30–34, 1988
5. Quesada JR, Kurzrock R, Sherwin SA, Gutterman JU: Phase II studies of recombinant human gamma in metastatic renal cell carcinoma. J Biol Resp Mod 6: 20–27, 1987